![1]()
News
Children and COVID: New cases soar to near-record level
August 24, 2021
Vaccine initiations were down for the second consecutive week, but COVID-related deaths showed a big increase.
![1]()
News
CRP as a biomarker for community-acquired pneumonia
August 24, 2021
Can biomarkers such as C-reactive protine (CRP) or procalcitonin be used as tools in diagnosis of outpatient CAP (community-acquired pneumonia)?
News
COVID-19 booster shots to start in September: Officials
August 18, 2021
Booster shots to ramp up protection against COVID-19 infection are slated to begin the week of Sept. 20, the Biden administration announced at a press briefing August 18.Those who received the Pfizer-BioNTech and Moderna vaccines ...
News
Latest data show increase in breakthrough COVID-19 cases
August 18, 2021
“Remember when the early vaccine studies came out, it was like nobody gets hospitalized, nobody dies. ... That clearly is not true.”
![1]()
News
Children and COVID: New cases rise to winter levels
August 17, 2021
Since late June, weekly infections in children have increased by almost 1,400%.
News
Febrile infant guideline allows wiggle room on hospital admission, testing
August 12, 2021
Evidence-based guidelines use language to guide, but not direct, clinicians in balancing the risks of infections and invasive procedures.
News
COVID-19 mitigation measures led to shifts in typical annual respiratory virus patterns
August 11, 2021
“Clinicians should be aware of increases in some respiratory virus activity and remain vigilant for off-season increases.”
![1]()
News
Surge of new child COVID cases continues for 6th consecutive week
August 10, 2021
Upward trend in vaccine initiation is now in its 4th week among 12- to 15-year-olds.
![1]()
News
Fauci says ‘unprecedented’ conditions could influence COVID vaccine approval for kids
August 6, 2021
“If I were a [non-COVID] virus looking for a niche, I would be really confused,” Dr. Fauci told pediatric hospitalists.
![1]()
News
Injectable monoclonal antibodies prevent COVID-19 in trial
August 6, 2021
The cocktail of casirivimab and imdevimab reduced the relative risk of infection by 72% in patients at high risk of infection.
